Pegasus's 86% price decline "coincides with the publication of 11 negative research notes from July through August by well-known short-seller Manuel Asensio.

Liz Moyer. Forbes

Other resources of interest

A closer look at Manuel Asensio biography, Manuel Asensio positive outcomes, Manuel Asensio Reports, Manuel Asensio Research Legacy and other related information to Manuel Asensio
 
A closer look at Manuel Asensio biography, Manuel Asensio positive outcomes, Manuel Asensio Reports, Manuel Asensio Research Legacy and other related information to Manuel Asensio.
A closer look at Manuel Asensio biography, Manuel Asensio positive outcomes, Manuel Asensio Reports, Manuel Asensio Research Legacy and other related information to Manuel Asensio.
A closer look at Manuel Asensio biography, Manuel Asensio positive outcomes, Manuel Asensio Reports, Manuel Asensio Research Legacy and other related information to Manuel Asensio.
Manuel Asensio Report: Nov. 05, 1998 BioTime loses its prime sponsor.
Manuel Asensio and Asensio & Company, Inc. ("Asensio") report that David K. Crossen, an analyst covering BioTime, Inc. (Symbol: BTIM) (Price: $11.75) is no longer employed at NationsBanc Montgomery Securities, Inc. Mr. Crossen wrote at least 19 reports on BioTime. According to Manuel Asensio and Asensio, Crossen's reports contained numerous material omissions of fact, false statements and factual errors. Since Mr. Crossen’s departure, no analyst at NationsBanc Montgomery has picked up coverage of BioTime.
 
A closer look at Manuel Asensio biography, Manuel Asensio positive outcomes, Manuel Asensio Reports, Manuel Asensio Research Legacy and other related information to Manuel Asensio.
© 2010 Asensioexposes!com offers accurate facts that disproves past criticism of the Manuel Asensio Reports. Web Directory
A closer look at Manuel Asensio biography, Manuel Asensio positive outcomes, Manuel Asensio Reports, Manuel Asensio Research Legacy and other related information to Manuel Asensio.